Cargando…
The antibody response of haematological malignancies to COVID-19 infection and vaccination
Cancer patients with COVID-19 have reduced survival. While most cancer patients, like the general population, have an almost 100% rate of seroconversion after COVID-19 infection or vaccination, patients with haematological malignancies have lower seroconversion rates and are far less likely to gain...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751459/ https://www.ncbi.nlm.nih.gov/pubmed/35017657 http://dx.doi.org/10.1038/s41416-021-01682-6 |